Z. M. Younossi, Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, vol.64, pp.73-84, 2016.

V. T. Samuel and G. I. Shulman, Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases, Cell Metab, vol.27, pp.22-41, 2018.

K. L. Donnelly, Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J Clin Invest, vol.115, pp.1343-1351, 2005.

E. Á. Hernández, Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance, The Journal of clinical investigation, vol.127, pp.695-708, 2017.

S. Tamura and I. Shimomura, Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease, J Clin Invest, vol.115, pp.1139-1142, 2005.

F. Marra, A. Gastaldelli, G. Svegliati-baroni, G. Tell, and C. Tiribelli, Molecular basis and mechanisms of progression of nonalcoholic steatohepatitis, Trends Mol Med, vol.14, pp.72-81, 2008.

L. Hebbard and J. George, Animal models of nonalcoholic fatty liver disease, Nat Rev Gastroenterol Hepatol, vol.8, pp.35-44, 2011.

Y. Rotman and A. J. Sanyal, Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease, Gut, vol.66, pp.180-190, 2017.

V. W. Wong, L. A. Adams, V. De-ledinghen, G. L. Wong, and S. Sookoian, Noninvasive biomarkers in NAFLD and NASH -current progress and future promise, Nat Rev Gastroenterol Hepatol, vol.15, pp.461-478, 2018.

B. Gross, M. Pawlak, P. Lefebvre, and B. Staels, PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD, Nat Rev Endocrinol, vol.13, pp.36-49, 2017.

G. Krey, Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay, Mol Endocrinol, vol.11, pp.779-791, 1997.

P. R. Devchand, The PPARalpha-leukotriene B4 pathway to inflammation control, Nature, vol.384, pp.39-43, 1996.

M. V. Chakravarthy, Identification of a physiologically relevant endogenous ligand for PPARalpha in liver, Cell, vol.138, pp.476-488, 2009.

V. Dubois, J. Eeckhoute, P. Lefebvre, and B. Staels, Distinct but complementary contributions of PPAR isotypes to energy homeostasis, J Clin Invest, vol.127, pp.1202-1214, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01709972

E. Ip, G. Farrell, P. Hall, G. Robertson, and I. Leclercq, Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice, Hepatology, vol.39, pp.1286-1296, 2004.

B. Staels, Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, Hepatology, vol.58, pp.1941-1952, 2013.

O. Braissant, F. Foufelle, C. Scotto, M. Dauca, and W. Wahli, Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat, Endocrinology, vol.137, pp.354-366, 1996.

S. Kersten, Integrated physiology and systems biology of PPARalpha, Mol Metab, vol.3, pp.354-371, 2014.

A. Montagner, Liver PPARalpha is crucial for whole-body fatty acid homeostasis and is protective against NAFLD, Gut, vol.65, pp.1202-1214, 2016.

M. Regnier, Insights into the role of hepatocyte PPARalpha activity in response to fasting, Mol Cell Endocrinol, vol.471, pp.75-88, 2018.

I. Goldstein and G. L. Hager, Transcriptional and Chromatin Regulation during Fasting -The Genomic Era, Trends Endocrinol Metab, vol.26, pp.699-710, 2015.

E. Hondares, Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat, Cell Metab, vol.11, pp.206-212, 2010.

D. G. Cotter, B. Ercal, D. A. Avignon, D. J. Dietzen, and P. A. Crawford, Impairments of hepatic gluconeogenesis and ketogenesis in PPARalpha-deficient neonatal mice, Am J Physiol Endocrinol Metab, vol.307, pp.176-185, 2014.

G. Rando, Glucocorticoid receptor-PPARalpha axis in fetal mouse liver prepares neonates for milk lipid catabolism, Elife, vol.5, 2016.

S. Kersten, Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting, J Clin Invest, vol.103, pp.1489-1498, 1999.

D. L. Kroetz, P. Yook, P. Costet, P. Bianchi, and T. Pineau, Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes, J Biol Chem, vol.273, p.31581, 1998.

T. C. Leone, C. J. Weinheimer, and D. P. Kelly, A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders, Proc Natl Acad Sci, vol.96, pp.7473-7478, 1999.

A. Polizzi, Hepatic Fasting-Induced PPARalpha Activity Does Not Depend on Essential Fatty Acids, Int J Mol Sci, vol.17, 2016.

S. Liu, A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use, Nature, vol.502, pp.550-554, 2013.

A. Tsuchida, Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination, Diabetes, vol.54, pp.3358-3370, 2005.

T. Goto, Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes, J Lipid Res, vol.52, pp.873-884, 2011.

V. Barquissau, White-to-brite conversion in human adipocytes promotes metabolic reprogramming towards fatty acid anabolic and catabolic pathways, Mol Metab, vol.5, pp.352-365, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02134884

M. Defour, The Peroxisome Proliferator-Activated Receptor alpha is dispensable for cold-induced adipose tissue browning in mice, Mol Metab, vol.10, pp.39-54, 2018.

M. Bunger, Genome-wide analysis of PPARalpha activation in murine small intestine, Physiol Genomics, vol.30, pp.192-204, 2007.

G. Haemmerle, ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1, Nat Med, vol.17, pp.1076-1085, 2011.

M. C. Sugden, K. Bulmer, G. F. Gibbons, and M. J. Holness, Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding, Arch Biochem Biophys, vol.395, pp.246-252, 2001.

P. Costet, Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis, J Biol Chem, vol.273, pp.29577-29585, 1998.
URL : https://hal.archives-ouvertes.fr/hal-02698845

M. A. Abdelmegeed, PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver, J Nutr, vol.141, pp.603-610, 2011.

D. Patsouris, J. K. Reddy, M. Muller, and S. Kersten, Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression, Endocrinology, vol.147, pp.1508-1516, 2006.

R. Stienstra, Peroxisome proliferator-activated receptor alpha protects against obesity-induced hepatic inflammation, Endocrinology, vol.148, pp.2753-2763, 2007.

E. Ip, Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice, Hepatology, vol.38, pp.123-132, 2003.

M. Guerre-millo, PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance, Diabetes, vol.50, pp.2809-2814, 2001.

D. Patsouris, PPARalpha governs glycerol metabolism, J Clin Invest, vol.114, pp.94-103, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-00546124

M. K. Badman, Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states, Cell Metab, vol.5, pp.426-437, 2007.

A. Iroz, A Specific ChREBP and PPARalpha Cross-Talk Is Required for the Glucose-Mediated FGF21 Response, Cell Rep, vol.21, pp.403-416, 2017.

A. Kharitonenkov, R. Dimarchi, and . Revolutions, Recent Advances Illuminating FGF21 Biology and Medicinal Properties, vol.26, pp.608-617, 2015.

F. M. Fisher, Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets, Gastroenterology, vol.147, pp.1073-1083, 1076.

G. Singhal, Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet, Mol Metab, vol.13, pp.56-66, 2018.

D. E. Kleiner, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, vol.41, pp.1313-1321, 2005.

J. A. Van-diepen, PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism, J Hepatol, vol.61, pp.366-372, 2014.

C. Estes, H. Razavi, R. Loomba, Z. Younossi, and A. J. Sanyal, Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease, Hepatology, vol.67, pp.123-133, 2018.

G. Wettstein, The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis, Hepatol Commun, vol.1, pp.524-537, 2017.

V. Ratziu, Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-alpha and -delta, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening, Gastroenterology, vol.150, pp.1147-1159, 1145.

S. S. Lee, Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators, Mol Cell Biol, vol.15, pp.3012-3022, 1995.
URL : https://hal.archives-ouvertes.fr/hal-02712129

S. Francque, PPARalpha gene expression correlates with severity and histological treatment response in patients with nonalcoholic steatohepatitis, J Hepatol, vol.63, pp.164-173, 2015.

C. Ma, NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis, Nature, vol.531, pp.253-257, 2016.

R. M. Mansouri, E. Bauge, B. Staels, and P. Gervois, Systemic and distal repercussions of liver-specific peroxisome proliferatoractivated receptor-alpha control of the acute-phase response, Endocrinology, vol.149, pp.3215-3223, 2008.

M. Pawlak, P. Lefebvre, and B. Staels, Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease, J Hepatol, vol.62, pp.720-733, 2015.

C. N. Brocker, Extrahepatic PPARalpha modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice, J Lipid Res, vol.59, pp.2140-2152, 2018.

G. Farrell, Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis, Hepatology, vol.69, pp.2241-2257, 2019.

J. M. Ruijter, Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data, Nucleic Acids Res, vol.37, 2009.

R. Edgar, M. Domrachev, and A. E. Lash, Gene Expression Omnibus: NCBI gene expression and hybridization array data repository, Nucleic Acids Res, vol.30, pp.207-210, 2002.

E. G. Bligh and W. J. Dyer, A rapid method of total lipid extraction and purification, Can J Biochem Physiol, vol.37, pp.911-917, 1959.

B. M. Bolstad, R. A. Irizarry, M. Astrand, and T. P. Speed, A comparison of normalization methods for high density oligonucleotide array data based on variance and bias, Bioinformatics, vol.19, pp.185-193, 2003.

M. E. Ritchie, limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Res, vol.43, 2015.

Y. Benjamini and Y. Hochberg, Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing, Royal statistical society, vol.57, pp.289-300, 1995.

L. Cao, K. A. Boitard, S. Besse, and P. , Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems, BMC Bioinformatics, vol.12, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00959981

L. Cao and K. A. , MixMC: A Multivariate Statistical Framework to Gain Insight into Microbial Communities, PLoS One, vol.11, 2016.

D. Szklarczyk, STRING v10: protein-protein interaction networks, integrated over the tree of life, Nucleic Acids Res, vol.43, pp.447-452, 2015.

Y. Zhou, Metascape provides a biologist-oriented resource for the analysis of systems-level datasets, Nat Commun, vol.10, pp.1523-1523, 2019.